Uric acid and hypertension in adolescents

Seminars in Nephrology

Volumn 25, Issue 1, 2005, Pages 32-38

  Feig, Daniel I ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATHEROSCLEROSIS; BLOOD PRESSURE MONITORING; BODY MASS; CARDIOVASCULAR RISK; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FREQUENCY ANALYSIS; HUMAN; HYPERTENSION; HYPERURICEMIA; MEDICAL RESEARCH; MORBIDITY; PATHOGENESIS; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; STATISTICAL SIGNIFICANCE; TECHNIQUE; URIC ACID BLOOD LEVEL;

EID: 12344266078     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semnephrol.2004.09.006     Document Type: Article

References (78)

1. S.E. Furner, J. Maurer, H. Rosenberg Health data on older Americans: United States, 1992 Mortality. Vital Health Stat 3 1993 77 112
2. V.L. Burt, P. Whelton, E.J. Roccella Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991 Hypertension 25 1995 305 313
3. S. MacMahon, B. Neal, A. Rodgers Blood pressure lowering for the primary and secondary prevention of coronary and cerebrovascular disease Schweiz Med Wochenschr 125 1995 2479 2486
4. M.J. Klag, P.K. Whelton, B.L. Randall Blood pressure and end-stage renal disease in men N Engl J Med 334 1996 13 18
5. J. Coresh, J.C. Longenecker, E.R. Miller 3rd Epidemiology of cardiovascular risk factors in chronic renal disease J Am Soc Nephrol 9 1998 S24 S30
6. J. Coresh, G.L. Wei, G. McQuillan Prevalence of high blood pressure and elevated serum creatinine level in the United States Findings from the third National Health and Nutrition Examination Survey (1988-1994) Arch Intern Med 161 2001 1207 1216
7. Multiple Risk Factor Intervention Trial Research Group Multiple risk factor intervention trial. Risk factor changes and mortality results JAMA 248 1982 1465 1477
8. R. Pontremoli, F. Viazzi, M. Ravera Long term effect of nifedipine GITS and lisinopril on subclinical organ damage in patients with essential hypertension J Nephrol 14 2001 19 26
9. J. Taguchi, E.D. Freis Partial reduction of blood pressure and prevention of complications in hypertension N Engl J Med 291 1974 329 331
10. S.H. Zinner, B. Rosner, W. Oh Significance of blood pressure in infancy. Familial aggregation and predictive effect on later blood pressure Hypertension 7 1985 411 416
11. R.M. Lauer, W.R. Clarke Childhood risk factors for high adult blood pressure the Muscatine study Pediatrics 84 1989 633 641
12. C.L. Shear, G.L. Burke, D.S. Freedman Value of childhood blood pressure measurements and family history in predicting future blood pressure status Results from 8 years of follow-up in the Bogalusa Heart Study Pediatrics 77 1986 862 869
13. G.L. Burke, R.A. Arcilla, W.S. Culpepper Blood pressure and echocardiographic measures in children The Bogalusa Heart Study Circulation 75 1987 106 114
14. S.D. Daniels, R.A. Meyer, J.M. Loggie Determinants of cardiac involvement in children and adolescents with essential hypertension Circulation 82 1990 1243 1248
15. R. Pontremoli, C. Nicolella, F. Viazzi Microalbuminuria is an early marker of target organ damage in essential hypertension Am J Hypertens 11 1998 430 438
16. M.B. Lande, J.M. Kaczorowski, P. Auinger Elevated blood pressure and decreased cognitive function among school-age children and adolescents in the United States J Pediatr 143 2003 720 724
17. R.E. Kavey, S.R. Daniels, R.M. Lauer American Heart Association guidelines for primary prevention of atherosclerotic cardiovascular disease beginning in childhood J Pediatr 142 2003 368 372
18. National High Blood Pressure Education Program Working Group on Hypertension Control in Children and Adolescents Update on the 1987 task force report on high blood pressure in children and adolescents A working group report from the National High Blood Pressure Education Program Pediatrics 98 1996 649 658
19. Task Force on Blood Pressure Control in Children Report of the second task force on blood pressure control in children--1987. National Heart, Lung, and Blood Institute, Bethesda, Maryland Pediatrics 79 1987 1 25
20. J.M. Sorof, J. Turner, D.S. Martin Cardiovascular risk factors and sequelae in hypertensive children identified by referral versus school-based screening Hypertension 43 2004 214 218
21. M. Soergel, M. Kirschstein, C. Busch Oscillometric twenty-four-hour ambulatory blood pressure values in healthy children and adolescents A multicenter trial including 1141 subjects J Pediatr 130 1997 178 184
22. J.L. Hornsby, P.F. Mongan, A.T. Taylor 'White coat' hypertension in children J Fam Pract 33 1991 617 623
23. P. Palatini, P. Mormino, M. Santonastaso Ambulatory blood pressure predicts end-organ damage only in subjects with reproducible recordings. HARVEST study investigators. Hypertension and Ambulatory Recording Venetia Study J Hypertens 17 1999 465 473
24. P. Verdecchia, G. Schillaci, M. Guerrieri Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension Circulation 81 1990 528 536
25. R. Zweiker, B. Eber, M. Schumacher "Non-dipping" related to cardiovascular events in essential hypertensive patients Acta Med Austriaca 21 1994 86 89
26. S.M. Bartosh, A.J. Aronson Childhood hypertension. An update on etiology, diagnosis, and treatment Pediatr Clin North Am 46 1999 235 252
27. A.B. Gruskin, S. Dabbagh, L.F. Fleishcmann Mechanisms of hypertension in childhood diseases T.M. Barratt E.D. Avner W. Harmon Pediatric Nephrology (ed 4) 1999 Williams & Wilkins Baltimore 987 1006
28. R.D. Swinford, J.R. Ingelfinger Evaluation of hypertension in childhood diseases T.M. Barratt E.D. Avner W. Harmon Pediatric Nephrology (ed 4) 1999 Williams & Wilkins Baltimore 1007 1030
29. V.F. Norwood Hypertension Pediatr Rev 23 2002 197 208
30. M.G. Masding, J.R. Jones, E. Bartley Assessment of blood pressure in patients with type 2 diabetes Comparison between home blood pressure monitoring, clinic blood pressure measurement and 24-h ambulatory blood pressure monitoring Diabet Med 18 2001 431 437
31. J.M. Sorof, T. Poffenbarger, K. Franco Evaluation of white coat hypertension in children Importance of the definitions of normal ambulatory blood pressure and the severity of casual hypertension Am J Hypertens 14 2001 855 860
32. F.A. Mohamed On chronic Bright's disease, and its essential symptoms Lancet 1 1879 399 401
33. P.J. Cannon, W.B. Stason, F.E. Demartini Hyperuricemia in primary and renal hypertension N Engl J Med 275 1966 457 464
34. D. Kinsey, R. Walther, H.S. Sise Incidence of hyperuricemia in 400 hypertensive subjects Circulation 24 1961 972 973
35. R. Klein, B.E. Klein, J.C. Cornoni Serum uric acid. Its relationship to coronary heart disease risk factors and cardiovascular disease, Evans County, Georgia Arch Intern Med 132 1973 401 410
36. J.V. Selby, G.D. Friedman, C.P. Quesenberry Jr Precursors of essential hypertension Pulmonary function, heart rate, uric acid, serum cholesterol, and other serum chemistries Am J Epidemiol 131 1990 1017 1027
37. F. Jossa, E. Farinaro, S. Panico Serum uric acid and hypertension The Olivetti heart study J Hum Hypertens 8 1994 677 681
38. I. Rovda Iu, L.M. Kazakova, E.A. Plaksina [Parameters of uric acid metabolism in healthy children and in patients with arterial hypertension] Pediatriia 8 1990 19 22
39. E. Torok, I. Gyarfas, M. Csukas Factors associated with stable high blood pressure in adolescents J Hypertens Suppl 3 suppl 3 1985 S389 S390
40. A.B. Gruskin The adolescent with essential hypertension Am J Kidney Dis 6 1985 86 90
41. D.I. Feig, R.J. Johnson Hyperuricemia in childhood primary hypertension Hypertension 42 2003 247 252
42. H.S. Goldstein, P. Manowitz Relation between serum uric acid and blood pressure in adolescents Ann Hum Biol 20 1993 423 431
43. F.N. Brand, D.L. McGee, W.B. Kannel Hyperuricemia as a risk factor of coronary heart disease The Framingham Study Am J Epidemiol 121 1985 11 18
44. W.B. Kannel Metabolic risk factors for coronary heart disease in women Perspective from the Framingham Study Am Heart J 114 1987 413 419
45. L.M. Ruilope, J.L. Rodicio Renal surrogates in essential hypertension Clin Exp Hypertens 21 1999 609 614
46. M.C. Hochberg, J. Thomas, D.J. Thomas Racial differences in the incidence of gout. The role of hypertension Arthritis Rheum 38 1995 628 632
47. A.P. Hall, P.E. Barry, T.R. Dawber Epidemiology of gout and hyperuricemia. A long-term population study Am J Med 42 1967 27 37
48. G.M. Reaven The kidney An unwilling accomplice in syndrome X Am J Kidney Dis 30 1997 928 931
49. X. Wu, M. Wakamiya, S. Vaishnav Hyperuricemia and urate nephropathy in urate oxidase-deficient mice Proc Natl Acad Sci U S A 91 1994 742 746
50. B. Stavric, W.J. Johnson, H.C. Grice Uric acid nephropathy An experimental model Proc Soc Exp Biol Med 130 1969 512 516
51. M. Mazzali, J. Hughes, Y.G. Kim Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism Hypertension 38 2001 1101 1106
52. M. Mazzali, J. Kanellis, L. Han Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism Am J Physiol 282 2002 F991 F997
53. S. Watanabe, D.H. Kang, L. Feng Uric acid hominoid evolution and the pathogenesis of salt-sensitivity Hypertension 40 2002 355 360
54. D.H. Kang, T. Nakagawa, L. Feng A role for uric acid in the progression of renal disease J Am Soc Nephrol 13 2002 2888 2897
55. R.C. Harris, M.D. Breyer Physiological regulation of cyclooxygenase-2 in the kidney Am J Physiol 281 2001 F1 F11
56. D.I. Feig, T. Nakagawa, S.A. Karumanchi Hypothesis Uric acid, nephron number and the pathogenesis of essential hypertension Kidney Int 66 2004 281 287
57. L.K. Dahl, M. Heine Primary role of renal homografts in setting chronic blood pressure levels in rats Circ Res 36 1975 692 696
58. S. Sommers, R. Relman, R. Smithwick Histologic studies of kidney biopsy specimens from patients with hypertension Am J Pathol 34 1958 685 715
59. A. Moritz, M. Oldt Ateriolar sclerosis in hypertensive and nonhypertensive individuals Am J Pathol 13 1937 679 728
60. R.E. Tracy Renovasculopathies of hypertension and the rise of blood pressure with age in blacks and whites Semin Nephrol 16 1996 126 133
61. R.E. Tracy, G. Berenson, W. Wattigney The evolution of benign arterionephrosclerosis from age 6 to 70 years Am J Pathol 136 1990 429 439
62. D.J. Barker The fetal origins of adult hypertension J Hypertens Suppl 10 1992 S39 S44
63. D.J. Barker, C. Osmond, J. Golding Growth in utero, blood pressure in childhood and adult life, and mortality from cardiovascular disease BMJ 298 1989 564 567
64. B. Falkner, S. Hulman, H. Kushner Effect of birth weight on blood pressure and body size in early adolescence Hypertension 43 2004 203 207
65. J. Keller, G. Zimmer, G. Mall Nephron number in patients with primary hypertension N Engl J Med 348 2003 101 118
66. E.A. Anderson, C.A. Sinkey, W.J. Lawton Elevated sympathetic nerve activity in borderline hypertensive humans. Evidence from direct intraneural recordings Hypertension 14 1989 177 183
67. M. Esler, J. Turbott, R. Schwarz Differing noradrenaline kinetics in essential hypertension and depressive illness, two diseases in which the plasma concentration of noradrenaline is sometimes elevated Clin Exp Pharmacol Physiol 8 1981 525 530
68. T. Matsukawa, E. Gotoh, O. Hasegawa Reduced baroreflex changes in muscle sympathetic nerve activity during blood pressure elevation in essential hypertension J Hypertens 9 1991 537 542
69. R. Perondi, A. Saino, R.A. Tio ACE inhibition attenuates sympathetic coronary vasoconstriction in patients with coronary artery disease Circulation 85 1992 2004 2013
70. J.A. Panza, P.R. Casino, C.M. Kilcoyne Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension Circulation 87 1993 1468 1474
71. J.A. Panza, P.R. Casino, C.M. Kilcoyne Impaired endothelium-dependent vasodilation in patients with essential hypertension Evidence that the abnormality is not at the muscarinic receptor level J Am Coll Cardiol 23 1994 1610 1616
72. J.A. Panza, C.E. Garcia, C.M. Kilcoyne Impaired endothelium-dependent vasodilation in patients with essential hypertension. Evidence that nitric oxide abnormality is not localized to a single signal transduction pathway Circulation 91 1995 1732 1738
73. J.A. Panza, A.A. Quyyumi, J.E. Brush Jr Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension N Engl J Med 323 1990 22 27
74. R.J. Johnson, J. Herrera-Acosta, G.F. Schreiner Subtle acquired renal injury as a mechanism of salt-sensitive hypertension N Engl J Med 346 2002 913 923
75. R.J. Johnson, B. Rodriguez-Iturbe, G.F. Schreiner Hypertension A microvascular and tubulointerstitial disease J Hypertens Suppl 20 2002 S1 S7
76. D.H. Kang, T. Nakagawa, L. Feng Nitric oxide modulates vascular disease in the remnant kidney model Am J Pathol 161 2002 239 248
77. C.D. Furberg, J.T. Wright, B.R. Davis Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) JAMA 288 2002 2981 2997
78. L.M. Wing, C.M. Reid, P. Ryan A comparison of outcomes with angiotensin-converting-enzyme inhibitors and diuretics for hypertension in the elderly N Engl J Med 348 2003 583 592